| Literature DB >> 33173296 |
David Isaacs1, Alexandra P Key2,3,4, Carissa J Cascio4,5,6, Alexander C Conley2,6, Harrison C Walker7, Mark T Wallace3,5,6,8,9, Daniel O Claassen1.
Abstract
BACKGROUND: Sensory hypersensitivity, defined as heightened awareness of and reactivity to external stimuli, is a bothersome symptom that affects up to 80% of adults with Tourette syndrome (TS). Such widespread prevalence suggests sensory hypersensitivity is a core feature of the disorder, but its severity and association with other clinical features of TS remain largely unexplored. Complicating matters, sensory hypersensitivity has been observed in two neurodevelopmental disorders commonly comorbid with TS: obsessive-compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD).Entities:
Keywords: Tourette syndrome; obsessive-compulsive symptoms; sensory hypersensitivity; sensory sensitivity; tic disorder
Year: 2020 PMID: 33173296 PMCID: PMC7646442 DOI: 10.2147/NDT.S274165
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Clinical Rating Scales
| Scale Name | # of Scale Items | Scale Range | Score Interpretation |
|---|---|---|---|
| Sensory Gating Inventory (SGI) | 36 | 0–216 | Higher scores indicate more abnormal sensory gating experiences |
| Sensory Perception Quotient (SPQ) | 35 | 0–105 | Lower scores indicate greater sensory hypersensitivity |
| Dimensional Obsessive-Compulsive Scale (DOCS) | 20 | 0–80 | Higher scores indicate more obsessive-compulsive symptoms |
| Adult ADHD Self-Report Screening Scale for DSM-5 (ASRS-V) | 6 | 0–24 | Higher scores indicate more ADHD symptoms |
| Generalized Anxiety Disorder 7 (GAD-7) | 7 | 0–21 | Higher scores indicate more anxiety |
| Patient Health Questionnaire 9 (PHQ-9) | 9 | 0–27 | Higher scores indicate more depression |
| Premonitory Urge to Tic Scale (PUTS) | 10 | 9–36 | Higher scores indicate more severe premonitory urge |
| YGTSS Total Tic Score | 10 | 0–50 | Higher scores indicate more severe tics; the total score is comprised of two subscales: motor tic score (0–25) and phonic tic score (0–25) |
Note: *Administered to patients only.
Population Characteristics
| Tic Disorder Patients | Healthy Controls | |
|---|---|---|
| Sex (M:F) | 24:10 | 24:10 |
| Age (years) | 33.5 (22–49)^ | 33 (23–48) |
| Ethnicity | ||
| Hispanic or Latino | 0 | 2 |
| Not Hispanic or Latino | 34 | 30 |
| Unknown/not reported | 0 | 2 |
| Race | ||
| Asian | 1 | 2 |
| Black or African American | 0 | 2 |
| White | 32 | 28 |
| More than one race | 1 | 2 |
| Self-reported history of: | ||
| OCD | 18 | 0 |
| ADHD | 9 | 0 |
| Anxiety | 24 | 0 |
| Depression | 24 | 0 |
| Autism spectrum disorder | 0 | 0 |
| Impulse control disorder | 3 | 0 |
| Self-reported current use of psychotropic medications: | ||
| None | 5 | 32 |
| SSRI and/or SNRI | 20 | 0 |
| Benzodiazepine | 9 | 0 |
| Antipsychotic | 9 | 0 |
| Mood stabilizer+ | 6 | 0 |
| α-Agonist | 3 | 0 |
| Stimulant | 3 | 0 |
| Not reported | 0 | 2 |
Notes: ^Median (interquartile range). +In this sample, mood stabilizers used included lamotrigine, oxcarbazepine, and/or lithium.
Abbreviations: SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor.
Figure 1Scatterplot of SGI scores versus SPQ scores.
Scale Scores for Tic Disorder Patients and Healthy Controls
| Scale Name | Tic Disorder Patients | HC | Wilcoxon Rank Sum Statistic ( | |
|---|---|---|---|---|
| SGI Total | 119.0 (40.5) | 67.6 (19.0) | −5.3 | <0.0001 |
| SGI Subscale for Perceptual Modulation | 43.6 (17.7) | 22.1 (6.4) | −5.3 | <0.0001 |
| SGI Subscale for Distractibility | 31.9 (10.2) | 19.5 (8.9) | −4.5 | <0.0001 |
| SGI Subscale for Over-Inclusion and Hyperawareness | 24.5 (9.6) | 14.8 (6.0) | −4.0 | 0.0001 |
| SGI Subscale for Fatigue and Stress Vulnerability | 19.0 (6.9) | 11.3 (4.4) | −4.5 | <0.0001 |
| SPQ | 44.5 (16.3) | – | – | – |
| PUTS | 24.9 (4.9) | – | – | – |
| YGTSS Total Tic Score | 24.9 (10.7) | – | – | – |
| DOCS | 23.9 (16.3) | 8.9 (4.9) | −4.5 | <0.0001 |
| ASRS-V | 13.7 (4.5) | 6.1 (2.7) | −6.3 | <0.0001 |
| GAD-7 | 10.5 (5.8) | 2.9 (3.1) | −5.6 | <0.0001 |
| PHQ-9 | 10.9 (6.0) | 3.0 (2.6) | −5.8 | <0.0001 |
Note: *In each cell, mean (standard deviation) are listed above and median (interquartile range) below.
Correlation Matrix for Scales Within Patient Data Set
| TTS+ | PUTS | SGI | SPQ | DOCS | ASRS-V | PHQ-9 | |
|---|---|---|---|---|---|---|---|
| PUTS | 0.27 | ||||||
| SGI | 0.28 | 0.34* | |||||
| SPQ | −0.23 | −0.42* | −0.73*** | ||||
| DOCS | 0.44** | 0.35* | 0.34* | −0.35* | |||
| ASRS-V | 0.44** | 0.20 | 0.37* | −0.39* | 0.43* | ||
| PHQ-9 | 0.21 | 0.15 | 0.24 | −0.27 | 0.57*** | 0.58*** | |
| GAD-7 | 0.49** | 0.22 | 0.30 | −0.40* | 0.71*** | 0.32 | 0.48** |
Notes: *p < 0.05, **p < 0.01, ***p < 0.001. +YGTSS Total Tic Score.
Hierarchical Regression Model Analysis
| Model | Independent Variables (IVs) | VIF for Model IVs | Shapiro–Wilk Test for Normality of Model Residuals+ | Breusch–Pagan Test for Hetero-scedasticity, | Model | Model | Δ | AIC | IVs That Predict Mean SGI Score |
|---|---|---|---|---|---|---|---|---|---|
| 1^ | Age | 1.13 | 0.97 | 0.379 | – | 308 | None | ||
| Sex | 1.06 | ||||||||
| DOCS | 1.68 | ||||||||
| ASRS-V | 1.51 | ||||||||
| TTS | 1.66 | ||||||||
| 2 | Sex | 1.06 | 0.97 | 0.372 | Δ | 306 | DOCS, β = 1.03 | ||
| DOCS | 1.58 | ||||||||
| ASRS-V | 1.45 | ||||||||
| TTS | 1.59 | ||||||||
| 3 | DOCS | 1.58 | 0.98 | 0.358 | 305 | DOCS, β = 1.05 | |||
| ASRS-V | 1.45 | ||||||||
| TTS | 1.50 | ||||||||
| 4 | DOCS | 1.34 | 0.98 | 0.352 | 303 | DOCS, β = 1.15 | |||
| ASRS-V | 1.34 | ||||||||
| 5 | DOCS | – | 0.97 | 0.319 | Δ | 303 | DOCS, β = 1.41 |
Notes: ^Same three outliers excluded from all models given Cook's D > 4/n in Model 1. +p-value > 0.05 signifies inability to reject null hypothesis of normality of model residuals.